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Total costs of publishing (1998)
Total costs/article $ 6.000
(Incl. preparing manuscript 80-100 hours)
Readings/article 900 times
Costs/reading $ 6,70
Publisher’s costs 
(average per journal, 1998)
Fixed costs (processing, support) $ 400.000
Incremental costs/subscription
(reproduction, distribution) $ 40
Cost recovery / subscription
• 500 subscriptions $ 847
• 5000 subscriptions $ 48
Average subscription 1.900
Average price to recover costs $ 252
SAMPLE OF JOURNAL PRICES
1995 2001 % Change
Brain Research $10,181 $17,444 71.3%
Biochem. Biophys. Acta $7,555 $12,127        60.5%
Chem. Phys. Letters $5,279 $9,637          82.6%
Tetrahedron Letters $5,119 $9,036 76.5%
Eur. Jrnl. of Pharmacology $4,576 $7,889         72.4%
Gene $3,924 $7,443          89.7%
Inorganica Chem. Acta $3,611 $6,726          86.3%
Intl. Jrnl. of Pharmaceutics $3,006 $5,965          98.4%
Neuroscience $3,487 $6,270 79.8%
Theoretical Computer Science $2,774 $4,608           66.1%
Jrnl. of Exp. Marine Bio. & Eco. $1,947 $3,501 79.8%
Uit: Mary M. Case, Pittsburgh conference 2001: Scholarly Communication. A System in Crisis
Price increases by type of 
publisher
average price increase factor
1975 1995 current $ constant $
commercial $ 55 $ 487 8,9 3,1
society $ 28 $ 229 8,2 2,9
educational $ 15 $   81 5,4 1,9
other $ 40 $ 119 3,0 1,1
all types $ 39 $ 284 7,3 2,6
Cost effectiveness comparisons
price/page in $ price/citation in $
Field for-pr non-pr for-pr non-pr
Ecology 1.19 0.19 0.73 0.05
Economics 0.81 0.16 2.33 0.15
Atmos. Scie. 0.95 0.15 0.88 0.07
Mathematics 0.70 0.27 1.32 0.28
Neuroscience 0.89 0.10 0.23 0.04
Physics 0.63 0.19 0.38 0.05
Cost effectiveness comparisons: 
Cost/impact ratio 
Profit Non-profit
Physics 14.61 8.23
Economics 42.62 11.55
Neuroscience 8.69 0.64
Publishers of ISI-rated STM journals
1998 number share %
1   Elsevier Science comm 1347 18
2   Wolters Kluwer comm 552 7
3   Blackwell comm 341 4
4   Bertelsmann comm 326 4
5   Wiley comm 279 4
6   Taylor & Francis comm 191 2
7   Sage comm 123 2
8   Karger comm 101 1
9   Inst. E&E Engineers society 93 1
10 Cambridge Un. Press UP 84 1
11 Gordon & Breach comm 84 1
12 Oxford Un. Press UP 83              1
13 Marcel Dekker comm 76 1
14 Holzbrinck comm 67 1
15 Am. Inst. Of Physics society 41 1
Others (2034 publishers) 3922 50
Global scientific publishing market 
players 2001
2001 revenues ($mn)    2001 market share
Reed Elsevier 1.055,3 23,3 %
American Chem. Society 357,3 7,9 %
Thomson 259,0 5,7 %
John Wiley & Sons 243,6 5,4 %
Inst of Electrical & 
Electronic Engineers 200,3 4,4 %
Wolters Kluwer 169,3 3,7 %
McGraw Hill 146,2 3,2 %
Taylor & Francis 144,6 3,2 %
Springer Verlag 44,0 1,0 %
Others 4.536,4 42,3 %
Explanation for price rises?
• Reed Elsevier: “Investment in technology and 
increase of number of articles”
But: large differences between profit – non profit
• High proportion of journals with small print runs? 
Cross-subsidisation?
No evidence!
• Also: large differences between STM journal 
publishing and other commercial journal 
publishing (scholarly as well as others).
The market
“We believe that there is evidence 
that the market for STM journals 
may not be working well.”
Office of Fair Trading, September 2002
Antitrust
US antitrust rule of thumb:
Intervention is needed if one firm gains control of 
35% of the market.
But:
Each journal is a unique entity with a reputation 
and position in the scientific world. Some core 
titles are indispensable.
So: 
The 35% rule does not apply.
Mergers
• Since the 70s there has been a large number 
of take-overs and mergers: fewer 
publishers, larger publishers.
• New: Cinven & Candover wants to 
purchase BertellsmannSpringer (with 
Kluwer Academic); this would be the 
second largest publisher in the world.
Mergers
Mark McCabe: “Mergers are profitable for 
publishers.”
Merger between Pergamon (57 biomedical 
titles) and Elsevier (190) resulted in a price 
increase: P-titles 22%, E-titles 8%.
Merger between Lippincott and Kluwer:
35% price increase for former L-titles.
And also …
• 10 of 13 Elsevier’s new titles in 2001 
were drawn from scholarly 
associations.
• 10 of 35 Sage’s new titles in 2002 
represented societies’ contracts.
Big Deal
• 2/3 of the current academic journals have gone 
online, even as they continue to publish in print.
• Now we have not only large publishers but also 
large bundles: Big Deal.
• All or nothing: An online aggregation of journals 
that publishers offer as a one-price, one size fits all 
package.
Big Deal: consequences 
• Control mechanisms on demand and supply 
side disappear.
• No possibility to cancel individual titles.
• The chance of effective entry of new titles 
is low.
• Increasing problems as a result of mergers.
• The exit of the smallest publishers is more 
than likely.
Science Direct
Market penetration:
• 2000 35%
• 2002 69%
• End of 2003 75% (prediction)
Non-disclosure
Most licenses have non disclosure / 
confidentiality clauses.
Why? 
“It would generate more confusion and 
possibly consternation among customers 
who might not understand why there could 
be a discrepancy.” (Spokesman of Elsevier)
The benefit of Site licenses
Bergstrom & Bergstrom:
Journal site licenses are for the benefit of the 
academic community only if the subscription price 
is close to the publisher’s average cost.
If this is not the case, the selling of individual 
subscriptions would result in greater net benefits 
for the academic community.
Interlibrary loan
• Estimation 2000: 40 million copies
• Highly inefficient
• No electronic ILL permitted
• Pay per view: Science Direct $ 30/article
Interlibrary loan (2)
• The ILL systems do not generate any 
income for publishers.
• A new system (electronic ILL, pay per 
view) could benefit publishers, libraries and 
end-users.
• Publishers, however, are so afraid of loss of 
turn over, that they take no initiative.
Open access
• Institutional repositories
Larger commercial publishers are reluctant to give 
permission
• Free web access (immediately or later)
Only a small number of smaller commercial publishers
• New models (author payment, institutional membership)
BioMed Central
Large commercial publishers consider the Open Access 
movement to be a threat.
Trends in commercial publishing
• Benefits of scale will increasingly accrue to larger 
publishers
• Margins are likely to expand for those publishers 
with successful online platforms. The profitability 
improves by 15% as they move from print + 
online to online only
• But: budget cuts for libraries will cause a cyclical 
slowdown in the publishing industry
The advantages of e-publishing
• Libraries: 
“Open Access”
• Commercial publishers: 
“Towards higher profits”
What to do for the academic 
community?
Some scenarios:
• Influence the market by collective 
bargaining 
• A smaller role for traditional impact factors
• Change intellectual property rights
• Decoupling the reporting and dissemination 
of research from commercial publishing
